PQA has published a new report detailing technical recommendations for advancing health equity with PQA quality measures. Developed by the PQA Health Equity Technical Expert Panel (TEP), it provides key recommendations for PQA measure testing and use in quality programs.

PQA has appointed individuals from member organizations to serve on the 2025 PQA Measure Update Panel (MUP) and Quality Metrics Expert Panel (QMEP).

PQA has published more than 60 blogs this year, providing insights and updates on our work to improve medication use quality. As we close out 2024, here’s a look back at the top five blogs of the year.

This guest blog is one in a series by sponsors of the 2024 PQA Leadership Summit on how MedWatchers is using AI to empower better patient care. PQA does not endorse, recommend or favor any product, service or organization that is a sponsor.

This guest blog is one in a series by sponsors of the 2024 PQA Leadership Summit on why a large diverse clinical pharmacy network is so important to payer performance. PQA does not endorse, recommend or favor any product, service or organization that is a sponsor.

PQA is now is accepting self-nominations for the 2025 PQA Quality Shadowing Program. This program provides individuals from diverse groups the opportunity to observe PQA’s Quality Metrics Expert Panel or the Measure Update Panel.

PQA members and health quality professionals gathered in Arlington, Va., on November 7 for PQA Convenes: Quality Medication Use in Rare Disease. This half-day event brought together health care quality experts, rare disease leaders and individuals with lived experience to discuss what constitutes high-quality rare disease medication use.  

We are excited to host members next week at the 2024 PQA Leadership Summit and PQA Convenes: Quality Medication Use in Rare Disease at the Renaissance Arlington Capital View Hotel in Arlington, Va. This year's summit will focus on PQA's recent and ongoing work to develop standard pharmacy quality measures.

Every patient deserves access to medications that are safe, effective and can help them achieve the best outcomes possible. As our understanding and ability to treat rare disease improves, PQA is eager to shine a light on the aspects of quality medication use that benefit patients and those who care for them.

PQA offers a competitive Advanced Pharmacy Practice Experiential (APPE) Rotation for pharmacy students, which provides experiential learning opportunities in non-profit association management, medication use quality education, communications, research and performance measurement. PQA works with individual students to align their rotation experience with desired career goals and interests. Applications for the 2025-26 year are now being accepted. You can apply here. Visit our Student Programs page for more information. 

PQA is developing a set of standard pharmacy performance measures that would be appropriate for pharmacy quality assessment. As part of this work, PQA has launched a proof-of-concept pilot using several PQA pharmacy measure concepts to evaluate the effectiveness of pharmacies in improving adult immunization rates through value-based arrangements (VBA) with payers.

Chronic obstructive pulmonary disease (COPD) is a serious global health concern impacting millions of individuals. Despite being the third leading cause of mortality worldwide, COPD remains underdiagnosed and undertreated. Quality measures are a vital component of value-based payment models, but there are few COPD measures in current U.S. quality reporting programs, despite the established burden of COPD.

PQA offers a variety of student and professional programs, including experiential rotations, internships and fellowships. Each focuses on providing health care quality experience to diverse individuals from diverse disciplines. PQA is now accepting applications for our student and professional programs for 2025-2026.